Three Poster Presentations Demonstrate The Long-Term Efficacy of Mavorixafor in Primary Immunodeficiencies
X4 Pharmaceuticals Inc. has recently published data from 3 different posters which were presented at the American Society of Hematology (ASH) Annual Meeting in Georgia. You can read the full…